المؤلفون: Ghirardi A; FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy., Carobbio A; FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Materno-Infantili e dell'Adulto, Università di Modena-Reggio Emilia, Modena, Italy., Guglielmelli P; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Florence, Italy., Rambaldi A; Divisione di Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy., De Stefano V; Institute of Hematology, Catholic University, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Vannucchi AM; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Florence, Italy., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Barbui T; FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy. tbarbui@fondazionefrom.it.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Apr 22; Vol. 14 (1), pp. 68. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/complications , Myeloproliferative Disorders*/diagnosis , Thrombosis*/etiology , Thrombosis*/epidemiology , Thrombosis*/diagnosis, Humans ; Female ; Male ; Case-Control Studies ; Middle Aged ; Aged ; Adult ; Neoplasms, Second Primary/diagnosis ; Neoplasms, Second Primary/epidemiology ; Neoplasms, Second Primary/etiology ; Age Factors ; Aged, 80 and over ; Sex Factors

المؤلفون: Larsen MK; Department of Hematology, Zealand University Hospital, Roskilde, Denmark. Mortenkrankerlarsen1@hotmail.com.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Mortenkrankerlarsen1@hotmail.com., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Eickhardt-Dalbøge CS; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Knudsen TA; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Kristiansen MH; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Neurology, Zealand University Hospital, Roskilde, Denmark., Sørensen AL; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Wienecke T; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Neurology, Zealand University Hospital, Roskilde, Denmark., Andersen M; Department of Science and Environment, Roskilde University, Roskilde, Denmark., Ottesen JT; Department of Science and Environment, Roskilde University, Roskilde, Denmark., Gudmand-Høyer J; Department of Science and Environment, Roskilde University, Roskilde, Denmark., Snyder JA; Department of Science and Environment, Roskilde University, Roskilde, Denmark., Andersen MP; Department of Cardiology, Copenhagen University Hospital, Nordsjællands Hospital, Hillerød, Denmark., Torp-Pedersen C; Department of Cardiology, Copenhagen University Hospital, Nordsjællands Hospital, Hillerød, Denmark., Poulsen HE; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Copenhagen University Hospital, Nordsjællands Hospital, Hillerød, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Bispebjerg Frederiksberg Hospital, Copenhagen, Denmark., Stiehl T; Department of Science and Environment, Roskilde University, Roskilde, Denmark.; Institute for Computational Biomedicine - Disease Modelling, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ellervik C; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Zealand University Hospital, Koege, Denmark.; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Feb 09; Vol. 14 (1), pp. 28. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/epidemiology , Polycythemia Vera* , Primary Myelofibrosis*/epidemiology , Thrombocythemia, Essential*/epidemiology, Humans ; Longitudinal Studies ; Neutrophils ; Lymphocytes ; Denmark/epidemiology

المؤلفون: Gou P; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France.; Université de Paris Cité, Paris, France., Liu D; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France.; Université de Paris Cité, Paris, France., Ganesan S; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France., Lauret E; Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR 8104, Paris, France., Maslah N; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France.; Université de Paris Cité, Paris, France.; Service de Biologie Cellulaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Parietti V; Université de Paris Cité, Paris, France.; INSERM/CNRS US53/UAR2030, Institut de Recherche Saint-Louis, Paris, France., Zhang W; Université de Paris Cité, Paris, France., Meignin V; Université de Paris Cité, Paris, France.; Histo-pathological Department, Hôpital Saint-Louis, Paris, France., Kiladjian JJ; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France.; Université de Paris Cité, Paris, France.; Centre Investigations Cliniques, Hôpital Saint-Louis, Paris, France., Cassinat B; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France.; Service de Biologie Cellulaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Giraudier S; Inserm UMR-S 1131, Hôpital Saint-Louis, Paris, France. stephane.giraudier@aphp.fr.; Université de Paris Cité, Paris, France. stephane.giraudier@aphp.fr.; Service de Biologie Cellulaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France. stephane.giraudier@aphp.fr.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Jan 04; Vol. 14 (1), pp. 1. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/drug therapy , Myeloproliferative Disorders*/genetics , Leukemia, Myeloid, Acute*, Humans ; Mice ; Animals ; Tumor Suppressor Protein p53/genetics ; Janus Kinase 2/genetics ; Janus Kinase 2/metabolism ; Mutation ; Interferon-alpha/pharmacology ; Genomics

المؤلفون: Vieri M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Tharmapalan V; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany.; Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany., Kalmer M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Baumeister J; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Nikolić M; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany.; Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany., Schnitker M; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany.; Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany., Kirschner M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Flosdorf N; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany.; Institute for Biomedical Engineering-Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany., de Toledo MAS; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Zenke M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany.; Institute for Biomedical Engineering-Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany., Koschmieder S; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Beier F; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty of RWTH Aachen University, University Hospital Aachen, 52074, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Wagner W; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany. wwagner@ukaachen.de.; Helmholtz-Institute for Biomedical Engineering, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany. wwagner@ukaachen.de.; Institute for Stem Cell Biology, Medical Faculty of RWTH Aachen University, 52074, Aachen, Germany. wwagner@ukaachen.de.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Nov 06; Vol. 13 (1), pp. 164. Date of Electronic Publication: 2023 Nov 06.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/genetics , Myeloproliferative Disorders*/pathology , Neoplasms*/pathology, Humans ; Clone Cells/pathology ; Cellular Senescence

المؤلفون: Loscocco GG; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.; Doctorate School GenOMec, University of Siena, Siena, Italy., Gesullo F; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Capecchi G; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Atanasio A; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Maccari C; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Mannelli F; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy. amvannucchi@unifi.it., Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Jan 18; Vol. 14 (1), pp. 10. Date of Electronic Publication: 2024 Jan 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Thrombocythemia, Essential*/complications , Myeloproliferative Disorders*/complications , Thrombocytosis*/complications , Thrombosis*/etiology , Thrombosis*/genetics, Humans ; Male ; Female ; Middle Aged ; Leukocytosis/complications ; Mutation ; Janus Kinase 2/genetics ; Calreticulin/genetics

المؤلفون: Yang Y; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA., Abbas S; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA., Sayem MA; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA., Dutta A; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA., Mohi G; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA. gm7sj@virginia.edu.; University of Virginia Cancer Center, Charlottesville, VA, 22908, USA. gm7sj@virginia.edu.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Nov 27; Vol. 13 (1), pp. 171. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/genetics , Neoplasms* , Polycythemia* , Serine-Arginine Splicing Factors*/genetics, Animals ; Mice ; Janus Kinase 2/genetics ; Janus Kinase 2/metabolism ; Mutation ; Primary Myelofibrosis

المؤلفون: Badar T; Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, 32224, USA. badar.talha@mayo.edu., Vanegas YAM; Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, 32224, USA., Nanaa A; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA.; John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 60612, USA., Foran JM; Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, 32224, USA., Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Mangaonkar A; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Murthy H; Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, 32224, USA., Alkhateeb HB; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Viswanatha D; Division of Hematopathology, Mayo Clinic, Rochester, MN, 55905, USA., He R; Division of Hematopathology, Mayo Clinic, Rochester, MN, 55905, USA., Shah M; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Yi CA; Department of Hematology Oncology, Mayo Clinic, Phoenix, AZ, USA., Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Gangat N; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA., Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA. patnaik.mrinal@mayo.edu.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Sep 21; Vol. 13 (1), pp. 149. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders* , Myelodysplastic Syndromes*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy, Humans ; Splicing Factor U2AF/genetics ; Prognosis ; Mutation ; RNA-Binding Proteins

المؤلفون: Yamada T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. kvlqt1789@gmail.com., Mori T; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Yamashita D; Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan., Tai Y; Department of Dermatology, Kobe City Medical Center General Hospital, Kobe, Japan., Yamamoto R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Maruoka H; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan., Sakamoto K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan., Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Aug 09; Vol. 13 (1), pp. 119. Date of Electronic Publication: 2023 Aug 09.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/complications , Myelodysplastic Syndromes*/genetics , Myeloproliferative Disorders* , Neoplasms* , Skin Neoplasms*/complications , Skin Neoplasms*/genetics , Hematologic Neoplasms*, Humans ; Clonal Hematopoiesis ; Acute Disease ; Dendritic Cells

المؤلفون: Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. tefferi.ayalew@mayo.edu., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Jul 18; Vol. 13 (1), pp. 108. Date of Electronic Publication: 2023 Jul 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/diagnosis , Myeloproliferative Disorders*/epidemiology , Myeloproliferative Disorders*/therapy , Polycythemia Vera*/genetics, Humans ; Blast Crisis/therapy ; Retrospective Studies ; Neoplasm Recurrence, Local ; Mutation ; Chronic Disease

المؤلفون: Courdy C; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Platteeuw L; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Ducau C; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., De Araujo I; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Boet E; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Sahal A; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Saland E; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Edmond V; INSERM UMR1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Tavitian S; Service d'hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse III Paul Sabatier, Toulouse, France., Bertoli S; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France.; Service d'hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse III Paul Sabatier, Toulouse, France., Cougoul P; Service de médecine interne, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Granat F; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Poillet L; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Marty C; INSERM UMR1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Plo I; INSERM UMR1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Sarry JE; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France., Manenti S; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France., Mansat-De Mas V; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France. demas.veronique@iuct-oncopole.fr.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France. demas.veronique@iuct-oncopole.fr.; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse III Paul Sabatier, Toulouse, France. demas.veronique@iuct-oncopole.fr., Joffre C; Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, CNRS UMR 5071, Université de Toulouse, Toulouse, France. carine.joffre@inserm.fr.; Equipe labellisée La Ligue contre le Cancer 2018, Toulouse, France. carine.joffre@inserm.fr.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Jul 10; Vol. 13 (1), pp. 106. Date of Electronic Publication: 2023 Jul 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/drug therapy , Myeloproliferative Disorders*/genetics , Myeloproliferative Disorders*/metabolism , Neoplasms*, Mice ; Animals ; Janus Kinase 2 ; Protein Phosphatase 2/genetics ; Autophagy ; Mutation